Complications of therapy in hemophilia
Hilgartner, M.W.
Pediatrics 74(2): 290-291
1984
ISSN/ISBN: 0031-4005 PMID: 6462828 Document Number: 223984
Document emailed within 1 workday
Related Documents
Jones, P. 1979: Organization of hemophilia therapy. the role of the hemophilia center Sangre 24(5-C): 998-1004Lutze, G.; Schlote, A.; Beyer, H.; Kropf, S. 1985: Diagnosis of hemophilia and Willebrand-Jürgens syndrome. 2. Results of studies in hemophilia patients and hemophilia carriers Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(16): 479-483
Saraf, S.K.; Singh, O.P.; Singh, V.P. 2003: Peripheral nerve complications in hemophilia Journal of the Association of Physicians of India 51: 167-169
Négrier, C.; Vinciguerra, C.; Pinson, S.; Plauchu, H. 1998: Hemophilia. Diagnosis, genetics, complications La Revue du Praticien 48(6): 657-659
Mannucci, P.M.; Mendolicchio, L.; Gringeri, A. 2001: Use of prophylaxis to prevent complications of hemophilia Advances in Experimental Medicine and Biology 489: 59-64
Srivastava, R.K.; Sinha, R.S.; Mehrotra, V. 1984: Management of musculo-skeletal complications of hemophilia Indian Pediatrics 21(12): 965-970
Mimaya, J. 1981: Management of complications in hemophilia, with special reference to hepatitis Nihon Rinsho. Japanese Journal of Clinical Medicine 39(12): 3707-3714
Lancourt, J.E.; Gilbert, M.S.; Posner, M.A. 1977: Management of bleeding and associated complications of hemophilia in the hand and forearm Journal of Bone and Joint Surgery. American Volume 59(4): 451-460
Liskiewicz, Z.; Maj, S.; Ziemski, J.M. 1971: Renal complications during treatment of hematuria in hemophilia a with epsilon-aminocaproic acid (EACA) Polski Tygodnik Lekarski 26(4): 145-147
Hutaff, L.W. 1973: Specific therapy in hemophilia North Carolina Medical Journal 34(3): 193-196
Kurachi, K.; Yao, S.N. 1993: Gene therapy of hemophilia B Thrombosis and Haemostasis 70(1): 193-197
Weinger, R.S.; Cimo, P.L. 1978: Home therapy for hemophilia Texas Medicine 74(6): 57-60
Lillicrap, D.P.; Bridge, P.J.; Giles, A.R. 1990: Organization of a hemophilia genetic screening program. Ontario Hemophilia Study Group Progress in Clinical and Biological Research 324: 19-28
Ambriz-Fernández, R.; Reyna-Fregoso, M.P.; Pizzuto-Chávez, J.; Rodríguez-Moyado, H.; Farfán-Canto, J.M.; Trueba-Christy, E.; Collazo-Jaloma, J. 1985: Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. a study of the cooperative group of hemophilia Archivos de Investigacion Medica 16(3): 225-235
Brdicka, R. 2001: Gene therapy of hemophilia--the next disappointment? Casopis lekaru ceskych 140(20): 640-641
Nowak, K.; Zalewska-Szewczyk, B.; Stolarska, M.; Bodalski, J. 1994: Prophylactic replacement therapy of hemophilia Polski Tygodnik Lekarski 49(12-13): 271-272
Chao, H.; Walsh, C.E. 2004: AAV vectors for hemophilia B gene therapy Mount Sinai Journal of Medicine new York 71(5): 305-313
Nichols, S.; Mahoney, E.M.; Sirois, P.A.; Bordeaux, J.D.; Stehbens, J.A.; Loveland, K.A.; Amodei, N. 2000: HIV-associated changes in adaptive, emotional, and behavioral functioning in children and adolescents with hemophilia: results from the Hemophilia Growth and Development Study Journal of Pediatric Psychology 25(8): 545-556
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11